Please assess the completion status of the following clinical trial:

Trial Title: Simultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV infected~* \< 200 CD4+ cells/mL~* Active pulmonary tuberculosis (with or without extrapulmonary involvement)~Exclusion Criteria:~* Meningeal tuberculosis~* Unable to attend 96 wk follow-up

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: EXPERIMENTAL): Receives both, simultaneously antiretroviral therapy and antituberculosis therapy
- Group 2 (Type: EXPERIMENTAL): Receives only antituberculosis therapy, and 2 months afterwards antiretroviral therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).